Angelucci F, Cechova K, Amlerova J, Hort J (2019) Antibiotics, gut microbiota, and Alzheimer’s disease. J Neuroinflammation 16(1):108. https://doi.org/10.1186/s12974-019-1494-4

Article  PubMed  PubMed Central  Google Scholar 

Annweiler C, Fantino B, Parot-Schinkel E, Thiery S, Gautier J, Beauchet O (2011) Alzheimer’s disease—input of vitamin D with mEmantine assay (AD-IDEA trial): study protocol for a randomized controlled trial. Trials 20(12):230. https://doi.org/10.1186/1745-6215-12-230

Article  CAS  Google Scholar 

Atri A (2019) The Alzheimer’s disease clinical spectrum: diagnosis and management. Med Clin North Am 103(2):263–293. https://doi.org/10.1016/j.mcna.2018.10.009

Article  PubMed  Google Scholar 

Bai B, Vanderwall D, Li Y, Wang X, Poudel S, Wang H, Dey KK, Chen PC, Yang K, Peng J (2021) Proteomic landscape of Alzheimer’s disease: novel insights into pathogenesis and biomarker discovery. Mol Neurodegener 16(1):55. https://doi.org/10.1186/s13024-021-00474-z

Article  PubMed  PubMed Central  CAS  Google Scholar 

Beisteiner R, Matt E, Fan C, Baldysiak H, Schönfeld M, Philippi Novak T, Amini A, Aslan T, Reinecke R, Lehrner J, Weber A, Reime U, Goldenstedt C, Marlinghaus E, Hallett M, Lohse-Busch H (2019) Transcranial pulse stimulation with ultrasound in Alzheimer’s disease—a new navigated focal brain therapy. Adv Sci 7(3):1902583. https://doi.org/10.1002/advs.201902583

Article  Google Scholar 

Escott-Price V, Schmidt KM (2021) Probability of Alzheimer’s disease based on common and rare genetic variants. Alzheimers Res Ther 13(1):140. https://doi.org/10.1186/s13195-021-00884-7

Article  PubMed  PubMed Central  CAS  Google Scholar 

Hane FT, Robinson M, Lee BY, Bai O, Leonenko Z, Albert MS (2017) Recent progress in Alzheimer’s disease research, Part 3: diagnosis and treatment. J Alzheimers Dis 57(3):645–665. https://doi.org/10.3233/JAD-160907

Article  PubMed  PubMed Central  Google Scholar 

Jarrell JT, Gao L, Cohen DS, Huang X (2018) Network medicine for Alzheimer’s disease and traditional Chinese medicine. Molecules 23(5):1143. https://doi.org/10.3390/molecules23051143

Article  PubMed  PubMed Central  CAS  Google Scholar 

Johnson ECB, Dammer EB, Duong DM, Ping L, Zhou M, Yin L, Higginbotham LA, Guajardo A, White B, Troncoso JC, Thambisetty M, Montine TJ, Lee EB, Trojanowski JQ, Beach TG, Reiman EM, Haroutunian V, Wang M, Schadt E, Zhang B, Dickson DW, Ertekin-Taner N, Golde TE, Petyuk VA, De Jager PL, Bennett DA, Wingo TS, Rangaraju S, Hajjar I, Shulman JM, Lah JJ, Levey AI, Seyfried NT (2020) Large-scale proteomic analysis of Alzheimer’s disease brain and cerebrospinal fluid reveals early changes in energy metabolism associated with microglia and astrocyte activation. Nat Med. 26(5):769–780. https://doi.org/10.1038/s41591-020-0815-6

Article  PubMed  PubMed Central  CAS  Google Scholar 

Jun H, Bramian A, Soma S, Saito T, Saido TC, Igarashi KM (2020) Disrupted place cell remapping and impaired grid cells in a knockin model of Alzheimer’s disease. Neuron. 107(6):1095-1112.e6. https://doi.org/10.1016/j.neuron.2020.06.023

Article  PubMed  PubMed Central  CAS  Google Scholar 

Lloret A, Esteve D, Lloret MA, Cervera-Ferri A, Lopez B, Nepomuceno M, Monllor P (2019) When does Alzheimer’s disease really start? The role of biomarkers. Int J Mol Sci 20(22):5536. https://doi.org/10.3390/ijms20225536

Article  PubMed  PubMed Central  CAS  Google Scholar 

Megur A, Baltriukienė D, Bukelskienė V, Burokas A (2020) The microbiota-gut-brain axis and Alzheimer’s disease: neuroinflammation is to blame? Nutrients 13(1):37. https://doi.org/10.3390/nu13010037

Article  PubMed  PubMed Central  CAS  Google Scholar 

Reitz C (2015) Genetic diagnosis and prognosis of Alzheimer’s disease: challenges and opportunities. Expert Rev Mol Diagn 15(3):339–48. https://doi.org/10.1586/14737159.2015.1002469

Article  MathSciNet  PubMed  PubMed Central  CAS  Google Scholar 

Roe K (2022) An alternative explanation for Alzheimer’s disease and Parkinson’s disease initiation from specific antibiotics, gut microbiota dysbiosis and neurotoxins. Neurochem Res 47(3):517–530. https://doi.org/10.1007/s11064-021-03467-y

Article  ADS  PubMed  CAS  Google Scholar 

Se Thoe E, Fauzi A, Tang YQ, Chamyuang S, Chia AYY (2021) A review on advances of treatment modalities for Alzheimer’s disease. Life Sci 276:119129. https://doi.org/10.1016/j.lfs.2021.119129

Article  PubMed  CAS  Google Scholar 

Wang M, Song WM, Ming C, Wang Q, Zhou X, Xu P, Krek A, Yoon Y, Ho L, Orr ME, Yuan GC, Zhang B (2022) Guidelines for bioinformatics of single-cell sequencing data analysis in Alzheimer’s disease: review, recommendation, implementation and application. Mol Neurodegener 17(1):17. https://doi.org/10.1186/s13024-022-00517-z

Article  PubMed  PubMed Central  CAS  Google Scholar 

Zhang H, Zhang Y, Li Y, Wang Y, Yan S, Xu S, Deng Z, Yang X, Xie H, Li J (2021) Bioinformatics and network pharmacology identify the therapeutic role and potential mechanism of melatonin in AD and rosacea. Front Immunol 23(12):756550. https://doi.org/10.3389/fimmu.2021.756550

Article  CAS  Google Scholar